Karuna Therapeutics Email Format

Biotechnology ResearchMassachusetts, United States11-50 Employees

Karuna Therapeutics is a biotechnology research organization that is now part of Bristol Myers Squibb. It focuses on developing therapies for neurological and neuropsychiatric diseases. The company is headquartered in Boston, Massachusetts, and operates within the framework of a larger global pharmaceutical company.

Its customers are patients affected by neurological and neuropsychiatric disorders. Recent developments tied to its parent company include Bristol Myers Squibb appointing a General Manager for Saudi Arabia and Gulf Countries in June 2026, signaling ongoing global expansion of the parent company's operations.

Sign up for free to view info

Company overview Employee directory